Travere Therapeutics (TVTX) EBT Margin Growth (1y) (2015 - 2026)
Travere Therapeutics (TVTX) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 2,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,152.00 |
| Dec 31, 2025 | 8,667.00 |
| Sep 30, 2025 | 15,147.00 |
| Jun 30, 2025 | 11,742.00 |
| Mar 31, 2025 | 27,775.00 |
| Dec 31, 2024 | 11,579.00 |
| Sep 30, 2024 | 15,336.00 |
| Jun 30, 2024 | 18,784.00 |
| Mar 31, 2024 | -1,577.00 |
| Dec 31, 2023 | 9,520.00 |
| Sep 30, 2023 | 5,836.00 |
| Jun 30, 2023 | -3,711.00 |
| Mar 31, 2023 | 3,657.00 |
| Dec 31, 2022 | -34,777.00 |
| Sep 30, 2022 | -24,673.00 |
| Jun 30, 2022 | -20,794.00 |
| Mar 31, 2022 | -23,597.00 |
| Dec 31, 2021 | 29,558.00 |
| Sep 30, 2021 | -813.00 |
| Jun 30, 2021 | -1,765.00 |